CHGCF:OTCMKTS
Chugai Pharmaceutical Co Ltd
US$Â 37.68
arrow_upward
+1.37%(+0.51) Siku 1
9 Okt, 16:00:00 GMT -4 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya CHGCF...
Fungua
US$Â 35.51
Juu
US$Â 39.29
Chini
US$Â 35.51
Mtaji wa soko
10.11T
Wastani wa kiasi cha mauzo
elfu 11.21
Kiasi cha mauzo ya hisa
elfu 9.02
Juu kwa wiki 52
US$Â 68.08
Chini kwa wiki 52
US$Â 34.79
Beta
1.91
Hisa za wawekezaji
1.68B
Idadi ya wafanyakazi
elfu 5
Fungua
US$Â 35.51
Juu
US$Â 39.29
Chini
US$Â 35.51
Mtaji wa soko
10.11T
Wastani wa kiasi cha mauzo
elfu 11.21
Kiasi cha mauzo ya hisa
elfu 9.02
Juu kwa wiki 52
US$Â 68.08
Chini kwa wiki 52
US$Â 34.79
Beta
1.91
Hisa za wawekezaji
1.68B
Idadi ya wafanyakazi
elfu 5
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
AD HOC NEWS
·
saa 8 zilizopita
Chugai Pharmaceutical stock sits at EUR 33.94 in weekend trading
Wasifu
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
Kuhusu Chugai Pharmaceutical Co Ltd
Afisa Mkuu Mtendaji (CEO)Osamu Okuda
Wafanyakazielfu 5.1
Lilianzishwa10 Mac 1925
Makao makuu-
Sekta-
Tovutichugai-pharm.co.jp